These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11343257)

  • 1. Expression of hepatitis C virus proteins does not interfere with major histocompatibility complex class I processing and presentation in vitro.
    Moradpour D; Grabscheid B; Kammer AR; Schmidtke G; Groettrup M; Blum HE; Cerny A
    Hepatology; 2001 May; 33(5):1282-7. PubMed ID: 11343257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune selection in murine tumors. Ph.d thesis.
    Svane IM; Engel AM
    APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteasome activity limits the assembly of MHC class I molecules after IFN-gamma stimulation.
    Benham AM; Neefjes JJ
    J Immunol; 1997 Dec; 159(12):5896-904. PubMed ID: 9550386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential roles of protein oxidation and the immunoproteasome in MHC class I antigen presentation: the 'PrOxI' hypothesis.
    Teoh CY; Davies KJ
    Arch Biochem Biophys; 2004 Mar; 423(1):88-96. PubMed ID: 14871471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus mutation affects proteasomal epitope processing.
    Seifert U; Liermann H; Racanelli V; Halenius A; Wiese M; Wedemeyer H; Ruppert T; Rispeter K; Henklein P; Sijts A; Hengel H; Kloetzel PM; Rehermann B
    J Clin Invest; 2004 Jul; 114(2):250-9. PubMed ID: 15254592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
    Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation.
    Barel MT; Pizzato N; van Leeuwen D; Bouteiller PL; Wiertz EJ; Lenfant F
    Eur J Immunol; 2003 Jun; 33(6):1707-16. PubMed ID: 12778489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral interference with MHC class I antigen presentation pathway: the battle continues.
    Ambagala AP; Solheim JC; Srikumaran S
    Vet Immunol Immunopathol; 2005 Aug; 107(1-2):1-15. PubMed ID: 15978672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein.
    Johnson JM; Nicot C; Fullen J; Ciminale V; Casareto L; Mulloy JC; Jacobson S; Franchini G
    J Virol; 2001 Jul; 75(13):6086-94. PubMed ID: 11390610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major histocompatibility complex class-I presentation impaired in transgenic mice expressing hepatitis C virus structural proteins during dendritic cell maturation.
    Hiasa Y; Takahashi H; Shimizu M; Nuriya H; Tsukiyama-Kohara K; Tanaka T; Horiike N; Onji M; Kohara M
    J Med Virol; 2004 Oct; 74(2):253-61. PubMed ID: 15332274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by woodchuck hepatitis virus of class I major histocompatibility complex presentation on hepatocytes is mediated by virus envelope pre-S2 protein and can be reversed by treatment with gamma interferon.
    Wang J; Michalak TI
    J Virol; 2006 Sep; 80(17):8541-53. PubMed ID: 16912304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Construction of HLA-A2-peptide tetramer and application in HBV/HCV infection].
    Piao WH; He Y; Xi HL; Sun XT; Zhang HH; Xu JH; Zhao H; Xu WX; Li ZL; Wang GQ
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1818-22. PubMed ID: 15631781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins.
    Moradpour D; Kary P; Rice CM; Blum HE
    Hepatology; 1998 Jul; 28(1):192-201. PubMed ID: 9657112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation.
    Barel MT; Hassink GC; van Voorden S; Wiertz EJ
    Mol Immunol; 2006 Mar; 43(8):1258-66. PubMed ID: 16098592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of viral immune evasion proteins to inhibit MHC class I antigen processing and presentation.
    Zhou F
    Int Rev Immunol; 2009; 28(5):376-93. PubMed ID: 19811316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI31 is a modulator of proteasome formation and antigen processing.
    Zaiss DM; Standera S; Kloetzel PM; Sijts AJ
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14344-9. PubMed ID: 12374861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feline herpesvirus-1 down-regulates MHC class I expression in an homologous cell system.
    Montagnaro S; Longo M; Pacilio M; Indovina P; Roberti A; De Martino L; Iovane G; Pagnini U
    J Cell Biochem; 2009 Jan; 106(1):179-85. PubMed ID: 19009565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between viral fitness and immune escape within the hepatitis C virus protease.
    Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
    Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction of tapasin gene restores surface expression of HLA class I molecules, but not antigen presentation of an HIV envelope peptide in a hepatoma cell line.
    Matsui M; Machida S; Tomiyama H; Takiguchi M; Akatsuka T
    Biochem Biophys Res Commun; 2001 Jul; 285(2):508-17. PubMed ID: 11444872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential down-modulation of HLA-G and HLA-A2 or -A3 cell surface expression following human cytomegalovirus infection.
    Pizzato N; Garmy-Susini B; Le Bouteiller P; Lenfant F
    J Reprod Immunol; 2004 Jun; 62(1-2):3-15. PubMed ID: 15288176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.